UBS Group’s Rayliant NxtGen Multifactor Emerging Markets Equity ETF RWEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-35
Closed -$1.02K 10934
2026
Q1
$1.02K Sell
35
-12
-26% -$373 ﹤0.01% 9643
2025
Q4
$1.4K Sell
47
-3
-6% -$87 ﹤0.01% 9600
2025
Q3
$1.41K Buy
+50
New +$1.36K ﹤0.01% 9357
2025
Q2
Sell
-4,624
Closed -$104K 10747
2025
Q1
$104K Buy
4,624
+4,074
+741% +$94.8K ﹤0.01% 7026
2024
Q4
$13.1K Buy
+550
New +$14K ﹤0.01% 8166
2024
Q3
Sell
-860
Closed -$22K 9968
2024
Q2
$22K Buy
+860
New +$21.1K ﹤0.01% 7243
2022
Q3
Sell
-40
Closed -$1K 10814
2022
Q2
$1K Buy
+40
New +$877 ﹤0.01% 9946

Other funds holding RWEM

UBS Group's RWEM Position: Q2 2026 in Review

UBS Group sold out of Rayliant NxtGen Multifactor Emerging Markets Equity ETF (RWEM) in Q2 2026, closing a stake of 35 shares — an estimated $1.02K sold.

UBS Group first reported a position in RWEM in Q2 2022 and held it in 7 quarters. The position peaked at $104K in Q1 2025. 9 funds tracked by Wall St. Rank hold RWEM as of Q2 2026.

  • UBS Group reported no remaining Rayliant NxtGen Multifactor Emerging Markets Equity ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 35 Rayliant NxtGen Multifactor Emerging Markets Equity ETF shares in Q2 2026, an estimated $1.02K.
  • UBS Group first reported a position in Rayliant NxtGen Multifactor Emerging Markets Equity ETF in Q2 2022 and held it in 7 quarters.
  • UBS Group's Rayliant NxtGen Multifactor Emerging Markets Equity ETF position peaked at $104K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Rayliant NxtGen Multifactor Emerging Markets Equity ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.